Social Acceptability of COVID-19 Vaccines in Pakistan

February 23, 2021 updated by: Jafir Hussain Shirazi, Islamia University of Bahawalpur

Social Acceptability of COVID-19 Vaccines in Pakistan: Fear and Social Trends

Social settings of Pakistan is unique in the sense that it is composed of multilingual, multicultural and different ethnicities. Also their believes and faiths are so unpredictable. It is therefore observed that this social phenomenon affects the acceptability of new things in this area. Polio vaccination has not worked so well in the past. Iodized salt acceptability has also been criticized in the last decades and is a matter of controversy till now. This behavior has also developed before the commencement of vaccination of COVID-19 in Pakistan, as there are many rumors and fears circulating via social media amongst Pakistan. What will be the acceptance rate for this vaccination, the time will decide.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

986

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Capital Territory
      • Islamabad, Capital Territory, Pakistan, 44000
        • Islamabad City
    • Punjab
      • Bahawalpur, Punjab, Pakistan, 63100
        • Bahawalpur Rural and Urban Areas
      • Faisalābad, Punjab, Pakistan, 38000
        • Faisalabad city
      • Lahore, Punjab, Pakistan, 54000
        • Lahore City

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All residents of pakistan are eligible to be in included in the study regardless of their geo-location and residencey

Description

Inclusion Criteria:

  • Adult
  • Cooperative
  • Willing to participate in study
  • Pakistani citizen

Exclusion Criteria:

  • Minors
  • non-cooperative/unconconcious
  • non-citizen of Pakistan

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Islamabad Group
Individuals residing and surveyed in Islamabad
A structured questionnaire will be served to each participant of study after getting the verbal consent from him for inclusion into the study
Lahore Group
Individuals residing and surveyed in Lahore
A structured questionnaire will be served to each participant of study after getting the verbal consent from him for inclusion into the study
Faisalabad Group
Individuals residing and surveyed in Faisalabad
A structured questionnaire will be served to each participant of study after getting the verbal consent from him for inclusion into the study
Bahawalpur Group
Individuals residing and surveyed in Bahawalpur

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographics (Age)
Time Frame: Till 23 February 2021
This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their age, their response will be recorded.
Till 23 February 2021
Demographics (Weight)
Time Frame: Till 23 February 2021
This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their weight and their response will be recorded.
Till 23 February 2021
Demographics (Gender)
Time Frame: Till 23 February 2021
This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their gender and their response will be recorded.
Till 23 February 2021
Demographics (Education)
Time Frame: Till 23 February 2021
This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their level of education and their response will be recorded.
Till 23 February 2021
Demographics (Family set up)
Time Frame: Till 23 February 2021
This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their family set i.e. joint family or separate family and their response will be recorded.
Till 23 February 2021
Demographics (Residence)
Time Frame: Till 23 February 2021
This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their residence i.e. either in rural area or living in city and their response will be recorded.
Till 23 February 2021
Attitude, knowledge and behavior about COVID-19 Vaccine and its acceptance or rejection
Time Frame: Till 23 February 2021
As this is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about vaccines, knowledge about vaccines, about corona vaccine specifically, about efficacy of vaccines, about efficacy of COVID-19 vaccine. about acceptance or rejection of vaccine, if they will not have a shot of vaccine then reasons, if they will have shots then reason for vaccination. if they are fear off vaccines then their reasons
Till 23 February 2021

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation of Age with a particular behavior
Time Frame: Till the end of February 2021
Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.
Till the end of February 2021
Correlation of Weight with a particular behavior
Time Frame: Till 23 February 2021
Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.
Till 23 February 2021
Correlation of Gender with a particular behavior
Time Frame: Till 23 February 2021
Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.
Till 23 February 2021
Correlation of Education level with a particular behavior
Time Frame: Till 23 February 2021
Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.
Till 23 February 2021
Correlation of Family set up with a particular behavior
Time Frame: Till 23 February 2021
Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.
Till 23 February 2021
Correlation of Residence with a particular behavior
Time Frame: Till 23 February 2021
Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.
Till 23 February 2021
Respondents Attitude, knowledge and behavior about COVID-19 Vaccine and its acceptance or rejection
Time Frame: Till 23 February 2021
Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination. t-Test will be applied to observe any statistically significant difference between different co-variates
Till 23 February 2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jafir Shirazi, PhD, The Islamia University of Bahawalpur
  • Study Director: Anam Sharmeen, M. Phil, The Islamia University of Bahawalpur
  • Study Chair: Asfa Akbar, M. Phil, The Islamia University of Bahawalpur
  • Study Chair: Fouzia Akbar, M.Phil, The Islamia University of Bahawalpur

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 23, 2021

Primary Completion (Actual)

February 23, 2021

Study Completion (Actual)

February 23, 2021

Study Registration Dates

First Submitted

January 22, 2021

First Submitted That Met QC Criteria

January 26, 2021

First Posted (Actual)

January 27, 2021

Study Record Updates

Last Update Posted (Actual)

February 24, 2021

Last Update Submitted That Met QC Criteria

February 23, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • Living amongst the fear

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Social Acceptance, Social Anxiety

Clinical Trials on Questionnaire

3
Subscribe